KZR-261

N/A

Report date: 2025/12/20 20:00:11
NMEFirst In Class

Base Information

Drug NameKZR-261
Drug Alias NameKZR-261
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein transport protein Sec61 inhibitors
TargetsProtein transport protein Sec61
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKezar Life Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKezar Life Sciences Inc
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A